CXT vs DBD

For growth investors, Crane NXT, Co.

(CXT) is the stronger pick with 11. 4% revenue growth year-over-year, versus 1. 5% for Diebold Nixdorf, Incorporated (DBD). Crane NXT, Co. (CXT) offers the better valuation at 17. 6x trailing P/E (10. 6x forward), making it the more compelling value choice. Analysts rate Crane NXT, Co. (CXT) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Crane NXT, Co.

(CXT) is the cheapest at 17. 6x versus Diebold Nixdorf, Incorporated at 31. 1x. On forward P/E, Crane NXT, Co. is actually cheaper at 10. 6x.

Over the past 5 years, Diebold Nixdorf, Incorporated (DBD) delivered a total return of +283.

4%, compared to +36. 6% for Crane NXT, Co. (CXT). Over 10 years, the gap is even starker: DBD returned +285. 0% versus CXT's +172. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Diebold Nixdorf, Incorporated (DBD) is the lower-risk stock at 1.

20β versus Crane NXT, Co. 's 1. 40β — meaning CXT is approximately 16% more volatile than DBD relative to the S&P 500. On balance sheet safety, Crane NXT, Co. (CXT) carries a lower debt/equity ratio of 91% versus 106% for Diebold Nixdorf, Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Crane NXT, Co.

(CXT) is pulling ahead at 11. 4% versus 1. 5% for Diebold Nixdorf, Incorporated (DBD). On earnings-per-share growth, the picture is similar: Diebold Nixdorf, Incorporated grew EPS 677. 3% year-over-year, compared to -21. 6% for Crane NXT, Co.. Over a 3-year CAGR, CXT leads at 7. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Crane NXT, Co.

(CXT) is the more profitable company, earning 8. 8% net margin versus 2. 5% for Diebold Nixdorf, Incorporated — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CXT leads at 15. 9% versus 8. 8% for DBD. At the gross margin level — before operating expenses — CXT leads at 42. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Crane NXT, Co.

(CXT) trades at 10. 6x forward P/E versus 14. 2x for Diebold Nixdorf, Incorporated — 3. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CXT: 43. 6% to $63. 00.

In this comparison, CXT (1.

5% yield) pays a dividend. DBD does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Crane NXT, Co.

(CXT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 5% yield, +172. 4% 10Y return). Both have compounded well over 10 years (CXT: +172. 4%, DBD: +285. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CXT (Industrials) and DBD (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CXT is a small-cap deep-value stock; DBD is a small-cap quality compounder stock. CXT pays a dividend while DBD does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.